Initiation of MLL-rearranged AML is dependent on C/EBPα

Journal of Experimental Medicine

Volumn 211, Issue 1, 2014, Pages 5-13

  Ohlsson, Ewa ^a,b,c   Hasemann, Marie Sigurd ^a,b,c   Willer, Anton ^a,b,c   Lauridsen, Felicia Kathrine Bratt ^a,b,c   Rapin, Nicolas ^a,b,c,d   Jendholm, Johan ^a,b,c   Porse, Bo Torben ^a,b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c University of Copenhagen   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR HOXA9;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TUMOR; CELL DIFFERENTIATION; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE REARRANGEMENT; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC TISSUE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL TRANSFORMATION, NEOPLASTIC; COMPUTATIONAL BIOLOGY; DNA PRIMERS; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION;

EID: 84892504696     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130932     Document Type: Article

References (27)

1. Ayton, P.M., E.H. Chen, and M.L. Cleary. 2004. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein. Mol. Cell. Biol. 24:10470-10478. http://dx.doi.org/10.1128/MCB.24.23.10470-10478.2004.
2. Estey, E., and H. Döhner. 2006. Acute myeloid leukaemia. Lancet. 368:1894-1907. http://dx.doi.org/10.1016/S0140-6736(06)69780-8.
3. Gentles, A.J., S.K. Plevritis, R. Majeti, and A.A. Alizadeh. 2010. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA. 304:2706-2715. http://dx.doi.org/10 .1001/jama.2010.1862.
4. Haferlach, T., A. Kohlmann, L. Wieczorek, G. Basso, G.T. Kronnie, M.C. Béné, J. De Vos, J.M. Hernández, W.K. Hofmann, K.I. Mills, et al. 2010. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J. Clin. Oncol. 28:2529-2537. http://dx.doi.org/10.1200/JCO.2009.23.4732.
5. Hasemann, M.S., M.B. Schuster, A.K. Frank, K. Theilgaard-Mönch, T.A. Pedersen, C. Nerlov, and B.T. Porse. 2012. Phosphorylation of serine 248 of C/EBPα is dispensable for myelopoiesis but its disruption leads to a low penetrant myeloid disorder with long latency. PLoS ONE. 7:e38841. http://dx.doi.org/10.1371/journal.pone.0038841.
6. Irizarry, R.A., C. Wang, Y. Zhou, and T.P. Speed. 2009. Gene set enrichment analysis made simple. Stat. Methods Med. Res. 18:565-575. http://dx.doi.org/10.1177/0962280209351908.
7. Krivtsov, A.V., and S.A. Armstrong. 2007. MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer. 7:823-833. http://dx.doi.org/10.1038/nrc2253.
8. Kroon, E., J. Krosl, U. Thorsteinsdottir, S. Baban, A.M. Buchberg, and G. Sauvageau. 1998. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17:3714-3725. http://dx.doi.org/10.1093/emboj/17.13.3714.
9. Kühn, R., F. Schwenk, M. Aguet, and K. Rajewsky. 1995. Inducible gene targeting in mice. Science. 269:1427-1429. http://dx.doi.org/10.1126/science.7660125.
10. Langmead, B., C. Trapnell, M. Pop, and S.L. Salzberg. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10:R25. http://dx.doi.org/10.1186/gb-2009-10-3-r25.
11. Lee, Y.H., B. Sauer, P.F. Johnson, and F.J. Gonzalez. 1997. Disruption of the c/ebp alpha gene in adult mouse liver. Mol. Cell. Biol. 17:6014-6022.
12. Muntean, A.G., and J.L. Hess. 2012. The pathogenesis of mixed-lineage leukemia. Annu. Rev. Pathol. 7:283-301. http://dx.doi.org/10.1146/annurev-pathol-011811-132434.
13. Nerlov, C. 2004. C/EBPalpha mutations in acute myeloid leukaemias. Nat. Rev. Cancer. 4:394-400. http://dx.doi.org/10.1038/nrc1363.
14. Nguyen, A.T., and Y. Zhang. 2011. The diverse functions of Dot1 and H3K79 methylation. Genes Dev. 25:1345-1358. http://dx.doi.org/10.1101/gad .2057811.
15. Reckzeh, K., and J. Cammenga. 2010. Molecular mechanisms underlying deregulation of C/EBPalpha in acute myeloid leukemia. Int. J. Hematol. 91:557-568. http://dx.doi.org/10.1007/s12185-010-0573-1.
16. Slany, R.K. 2009. The molecular biology of mixed lineage leukemia. Haematologica. 94:984-993. http://dx.doi.org/10.3324/haematol.2008.002436.
17. Smyth, G.K. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:3.
18. Somervaille, T.C., and M.L. Cleary. 2006. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell. 10:257-268. http://dx.doi.org/10.1016/j.ccr.2006 .08.020.
19. Subramanian, A., P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102:15545-15550. http://dx.doi.org/10.1073/pnas.0506580102.
20. Ventura, A., D.G. Kirsch, M.E. McLaughlin, D.A. Tuveson, J. Grimm, L. Lintault, J. Newman, E.E. Reczek, R. Weissleder, and T. Jacks. 2007. Restoration of p53 function leads to tumour regression in vivo. Nature. 445:661-665. http://dx.doi.org/10.1038/nature05541.
21. Wagner, K., P. Zhang, F. Rosenbauer, B. Drescher, S. Kobayashi, H.S. Radomska, J.L. Kutok, D.G. Gilliland, J. Krauter, and D.G. Tenen. 2006. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy. Proc. Natl. Acad. Sci. USA. 103:6338-6343. http://dx.doi.org/10.1073/pnas.0508143103.
22. Wang, Q.F., G. Wu, S. Mi, F. He, J. Wu, J. Dong, R.T. Luo, R. Mattison, J.J. Kaberlein, S. Prabhakar, H. Ji, and M.J. Thirman. 2011. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood. 117:6895-6905.
23. Weischenfeldt, J., I. Damgaard, D. Bryder, K. Theilgaard-Mönch, L.A. Thoren, F.C. Nielsen, S.E. Jacobsen, C. Nerlov, and B.T. Porse. 2008. NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev. 22:1381-1396. http://dx.doi.org/10.1101/gad.468808.
24. Wilhelm, B.T., M. Briau, P. Austin, A. Faubert, G. Boucher, P. Chagnon, K. Hope, S. Girard, N. Mayotte, J.R. Landry, et al. 2011. RNA-seq analysis of 2 closely related leukemia clones that differ in their self-renewal capacity. Blood. 117:e27-e38. http://dx.doi.org/10.1182/blood-2010-07-293332.
25. Wouters, B.J., B. Löwenberg, C.A. Erpelinck-Verschueren, W.L. van Putten, P.J. Valk, and R. Delwel. 2009. Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood. 113:3088-3091. http://dx.doi.org/10.1182/blood-2008-09-179895.
26. Zeisig, B.B., T. Milne, M.P. García-Cuéllar, S. Schreiner, M.E. Martin, U. Fuchs, A. Borkhardt, S.K. Chanda, J. Walker, R. Soden, et al. 2003. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol. Cell. Biol. 24:617-628. http://dx.doi.org/10.1128/MCB.24.2.617-628.2004.
27. Zhang, P., J. Iwasaki-Arai, H. Iwasaki, M.L. Fenyus, T. Dayaram, B.M. Owens, H. Shigematsu, E. Levantini, C.S. Huettner, J.A. Lekstrom-Himes, et al. 2004. Enhancement of hematopoietic stem cell repopulating capacity and selfrenewal in the absence of the transcription factor C/EBP alpha. Immunity. 21:853-863. http://dx.doi.org/10.1016/j.immuni.2004.11.006.